Literature DB >> 25426879

A brief review of survival prediction of advanced cancer patients.

Vincent Thai1, Yoko Tarumi, Gary Wolch.   

Abstract

Survival prediction of advanced cancer patients remains an important task for palliative clinicians. It has transformed from an art form into a more scientific branch of the discipline with the evolution of palliative medicine and use of statistical estimates of survival. Both clinician predicted survival and actuarial estimation of survival have their uses and drawbacks. This article gives a practical and quick summary of the pros and cons of clinician survival prediction and actuarial-based prognostic tools used at the bedside.

Entities:  

Keywords:  advanced; cancer; prognostic tools; prognostication; survival prediction

Mesh:

Year:  2014        PMID: 25426879     DOI: 10.12968/ijpn.2014.20.11.530

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  2 in total

1.  The prevalence of deranged C-reactive protein and albumin in patients with incurable cancer approaching death.

Authors:  Sarah Gray; Bertil Axelsson
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240

2.  Pretreatment neutrophil-to-lymphocyte ratio and its dynamic changes are associated with the overall survival in advanced cancer patients undergoing palliative care.

Authors:  Weiwei Zhao; Zhenyu Wu; Yintao Li; Huixun Jia; Menglei Chen; Xiaoli Gu; Minghui Liu; Zhe Zhang; Peng Wang; Wenwu Cheng
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.